Advantage Investment Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$59K Buy
512
+25
+5% +$3.79K 0.05% 309
2019
Q2
$84K Hold
487
0.06% 261
2019
Q1
$82K Sell
487
-75
-13% -$11.2K 0.06% 257
2018
Q4
$55K Hold
562
0.04% 329
2018
Q3
$97K Buy
562
+12
+2% +$1.73K 0.06% 278
2018
Q2
$77K Buy
550
+240
+77% +$34.1K 0.06% 301
2018
Q1
$35K Buy
310
+10
+3% +$1.26K 0.01% 453
2017
Q4
$40K Buy
300
+250
+500% +$29.4K 0.01% 447
2017
Q3
$5K Hold
50
﹤0.01% 832
2017
Q2
$5K Hold
50
﹤0.01% 852
2017
Q1
$6K Hold
50
﹤0.01% 791
2016
Q4
$6K Hold
50
﹤0.01% 731
2016
Q3
$7K Sell
50
-50
-50% -$4.78K ﹤0.01% 689
2016
Q2
$9K Sell
100
-200
-67% -$16.8K ﹤0.01% 618
2016
Q1
$22K Hold
300
0.01% 446
2015
Q4
$21K Buy
300
+100
+50% +$8.15K 0.01% 459
2015
Q3
$18K Hold
200
0.01% 473
2015
Q2
$25K Hold
200
0.01% 449
2015
Q1
$18K Sell
200
-723
-78% -$58.7K 0.01% 495
2014
Q4
$62K Buy
+923
New +$67.4K 0.05% 273

Other funds holding GWPH

Advantage Investment Management's GWPH Position: Q3 2019 in Review

Advantage Investment Management increased its GW Pharmaceuticals Plc American Depositary Shares (GWPH) stake by 5.1% in Q3 2019, buying an estimated $3.79K and bringing the position to 512 shares worth $59K. The position accounts for 0.05% of the portfolio, ranked #309.

Advantage Investment Management first reported a position in GWPH in Q4 2014 and has held it in 20 quarters since. The position peaked at $97K in Q3 2018. 316 funds tracked by Wall St. Rank hold GWPH as of Q3 2019.

  • Advantage Investment Management held 512 shares of GW Pharmaceuticals Plc American Depositary Shares worth $59K as of Q3 2019.
  • Advantage Investment Management bought 25 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2019, an estimated $3.79K.
  • GW Pharmaceuticals Plc American Depositary Shares made up 0.05% of Advantage Investment Management's portfolio in Q3 2019, its #309 holding.
  • Advantage Investment Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2014 and has held it in 20 quarters since.
  • Advantage Investment Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $97K in Q3 2018.
  • 316 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.